Scoppetta C, Albanese A, Caltagirone C.
Oligophrenia with the Hallermann-Streiff
syndrome. Journal of Neurology 220: 211-214, 1979
Albanese A,
Butcher LL. Locus ceruleus somata contain both
acetylcholinesterase and norepinephrine: direct histochemical
demonstration on the same tissue section. Neuroscience Letters,
14: 101-104, 1979
Albanese A,
Butcher LL. Acetylcholinesterase and catecholamine distribution in
the locus ceruleus of the rat. Brain Research Bulletin, 5: 127-134,
1980
Amaducci L, Sorbi
S, Albanese A, Gainotti G. Choline acetyltransferase (ChAT) activity
differs in right and left human temporal lobes. Neurology, 31:
799-805, 1981
Bentivoglio M,
Macchi G, Albanese A. The cortical projections of the thalamic intralaminar nuclei, as studied in cat and rat with the multiple
fluorescent retrograde tracer technique. Neuroscience Letters, 26:
5-10, 1981
Albanese A,
Bentivoglio M. The organization of dopaminergic and non-dopaminergic
mesencephalo-cortical neurons in the rat. Brain Research, 238:
421-425, 1982
Albanese A,
Bentivoglio M. Retrograde fluorescent neuronal tracing combined with acetylcholinesterase histochemistry. Journal of Neuroscience
Methods, 6: 121-127, 1982
Di Trapani G,
Pocchiari M, Masullo C, Albanese A, Tulli A.
Peripheral neuropathy
in the course of progressive systemic sclerosis: light and ultrastructural study. Italian Journal of Neurological Sciences, 3:
341-348, 1982
Caltagirone C,
Albanese A, Gainotti G, Masullo C.
Acute administration of
individual optimal dose of physostigmine fails to improve mnesic
performances in Alzheimer's presenile dementia. International.
Journal of Neuroscience, 18: 143-147, 1983
Albanese A,
Minciacchi D. Organization of the ascending efferent projections
from the ventral tegmental area: a multiple fluorescent retrograde
tracer study in the rat. Journal of Comparative Neurology, 216:
406-420, 1983
Albanese A,
Altavista MC. Neuropeptides in dopamine-containing regions of the
brain. Italian Journal of Neurological Sciences, 5: 391-404, 1984
Albanese A, Castagna M, Altavista MC. Cholinergic and non-cholinergic forebrain projections to the interpeduncular nucleus. Brain Research, 329: 334-339, 1985
Albanese A, Gozzo S, Iacopino C, Altavista
MC.
Strain-dependent variations in the number of forebrain cholinergic
neurons. Brain Research, 334: 380-384, 1985
Gozzo S, Iacopino
C, Altavista MC, Albanese A. Histochemical demonstration of heavy
metals in the reptilian archicortex. International Journal of
Neuroscience, 28: 11-19, 1985
Iacopino C,
Altavista MC, Gozzo S, Albanese A.
Quantitative pharmaco-histochemistry of acetylcholinesterase in neostriatum of
inbred strains of mice. Brain Research, 374: 402-408, 1986
Albanese A,
Altavista MC, Rossi P. Organization of central nervous system dopaminergic pathways. Journal of Neural Transmission Supplement 22:
3-17, 1986
Albanese A, Rossi P, Altavista MC.
Can trazodone
induce parkinsonism? Clinical Neuropharmacology, 11: 180-182, 1988
Albanese A,
Jenner P, Marsden CD, Stephenson JD.
Bladder hyperreflexia induced
in marmosets by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Neuroscience Letters, 87: 46-50, 1988
Altavista MC,
Bentivoglio AR, Crociani P, Rossi P, Albanese A.
Age-dependent loss
of cholinergic neurones in basal ganglia of rats. Brain Research,
455: 177-181, 1988
Willoughby J,
Glover V, Sandler M, Albanese A, Jenner P, Marsden CD.
Monoamine oxidase activity and distribution in marmoset brain: implications
for MPTP toxicity. Neuroscience Letters, 90: 100-106, 1988
Ueki A, Chong PN,
Albanese A, Rose S, Chivers JK, Jenner P, Marsden CD.
Further
treatment with MPTP does not produce parkinsonism in marmosets
showing behavioural recovery from motor deficits induced by an
earlier exposure to the toxin. Neuropharmacology, 28: 1089-1097,
1989
Altavista MC, Rossi P, Bentivoglio AR, Crociani P, Albanese A. Aging is associated with a diffuse impairment of forebrain cholinergic neurons. Brain Research, 508: 51-59, 1990
Albanese A, Altavista MC, Gozzo S, Rossi P, Colosimo C, Bentivoglio AR, Perretta G, Elia M, Monaco V, Macchi G. Chronic administration of MPTP to marmosets. Advances in Neurology, 53: 239-244, 1990
Colosimo C, Rossi P, Elia M, Bentivoglio AR, Altavista MC, Albanese A. Transient alternating hemichorea as presenting sign of progressive supranuclear palsy. Italian Journal of Neurological Sciences, 12: 99-101, 1991
Colosimo C, Granata R, Del Zompo M, Piccardi
MP, Perretta G, Albanese A. Chronic administration of MPTP to
monkeys: behavioural, morphological and biochemical correlates.
Neurochemistry International, 20: 279S-285S, 1992
Albanese A,
Colosimo C, Carretta D, Dickmann A, Bentivoglio AR, Tonali P.
Botulinum toxin as a treatment for blepharospasm, spasmodic
torticollis and hemifacial spasm. European Neurology, 32: 112-117,
1992
Albanese A,
Colosimo C, Bentivoglio AR, Bergonzi P.
Unsuspected, surreptitious
drug-induced parkinsonism. Neurology, 42: 459, 1992
Del Zompo M, Piccardi MP, Ruiu S, Albanese
A, M. Morelli.
Localization of MPP+ binding sites in the brain of various mammalian
species. Journal of Neural Transmission Parkinson's Disease and
Dementia Section, 4: 181-190, 1992
Albanese A,
Daniele A, Lo Monaco M, Di Lazzaro V, Restuccia D, Milone M, Tonali
P. Postural axial tremor in a patient with cerebellar atrophy.
Movement Disorders, 7: 273-280, 1992
Albanese A,
Granata R, Gregori B, Piccardi MP, Colosimo C, Tonali P.
Chronic
administration of 1-methyl-4-phenyl-1,2,3,6-tetra¬hydro¬pyridine to
monkeys: behavioural, morphological and biochemical correlates.
Neuroscience, 55: 823-832, 1993
Bentivoglio AR,
Altavista MC, Granata R, Albanese A. Genetically determined
cholinergic deficiency in the forebrain of C57BL/6 mice. Brain
Research, 637: 181-189, 1994
Colosimo C,
Merello M, Albanese A. Clinical usefulness of apomorphine in
movement disorders. Clinical Neuropharmacology, 17: 243-259, 1994
Gui D, Cassetta
E, Anastasio G, Bentivoglio AR, Maria G, Albanese A.
Botulinum toxin
for chronic anal fissure. Lancet, 344: 1127-1128, 1994
Colosimo C, Albanese A, De Bruin V, Hughes AJ, Lees AJ. Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson's disease. Archives of Neurology, 52: 294-298, 1995
Colosimo C, Cassetta E, Bentivoglio AR, Albanese A. Clozapine in Huntington’s disease. Neurology, 45: 1023, 1995
Albanese A, Colosimo C, Bentivoglio AR,
Fenici R, Melillo G, Colosimo C, Tonali P.
Multiple system atrophy
presenting as parkinsonism: clinical features and diagnostic
criteria. Journal of Neurology, Neurosurgery & Psychiatry, 59: 144-151, 1995
Colosimo C, Albanese A. Boxer disqualified for taking selegiline. Lancet, 346: 647, 1995
Albanese A, Cassetta E, Carretta D, Bentivoglio AR, Tonali P. Acute challenge with apomorphine in Huntington’s disease: a double-blind study. Clinical Neuropharmacology, 18: 427-434, 1995
Albanese A, Bentivoglio AR, Cassetta E, Viggiano A, Maria G, Gui D. The use of botulinum toxin on smooth muscles. European Journal of Neurology, 2: 29-33, 1995
Albanese A, Bentivoglio AR, Cassetta E, Viggiano A, Maria G, Gui D. The use of botulinum toxin in the alimentary tract. Alimentary Pharmacology and Therapeutics, 9: 599-604, 1995
Raja M, Altavista MC, Azzoni A, Albanese A. Severe barbiturate withdrawal syndrome in migrainous patients. Headache, 36: 119-121, 1996
Albanese A, Bentivoglio AR, Colosimo C, Galardi G, Maderna L, Tonali P. Pretarsal injections of botulinum toxin improve blepharospasm in previously unresponsive patients. Journal of Neurology, Neurosurgery & Psychiatry, 60: 693-694, 1996
Albanese A, Colosimo C, Lees AJ, Tonali P. The clinical diagnosis of multiple system atrophy presenting as pure parkinsonism. Advances in Neurology 69: 393-398, 1996
Raja M, Maisto G, Altavista MC, Albanese A. Tardive lingual dystonia treated with clozapine. Movement Disorders, 11: 585-586, 1996
Albanese A, Colosimo C, Lees AJ.
Multiple system
atrophy. Archives of Neurology 53: 212-213, 1996
Albanese A,
Gregori B, Carretta D, Tonali P.
Functional impairment of
nigrostriatal neurones progresses following withdrawal of
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience, 75:
1185-1191, 1996
Daniele A, Bartolomeo P, Cassetta E, Bentivoglio AR, Gainotti G, Albanese A. Obsessive-compulsive behaviour and cognitive impairment in a parkinsonian patient following left putaminal lesion. Journal of Neurology Neurosurgery & Psychiatry, 62: 288-289, 1997
Bentivoglio AR, Del Grosso N, Albanese A, Cassetta E, Tonali P, Frontali M. Non-DYT1 dystonia in a large Italian family. Journal of Neurology Neurosurgery & Psychiatry, 62: 357-360, 1997
Daniele A, Albanese A, Gainotti G, Gregori B, Bartolomeo P. Zolpidem in Parkinson’s disease. Lancet, 349: 1222-1223, 1997
Albanese A Emerging treatments in Parkinson’s disease. European Neurology, 38: 175-183, 1997
Albanese A, Maria G, Bentivoglio AR, Brisinda G, Cassetta E, Tonali P. Botulinum toxin in the treatment of chronic constipation in Parkinson’s disease. European Journal of Neurology, 4 (Supplement 2): S81-S83, 1997
Albanese A, Maria G, Bentivoglio AR, Brisinda G, Cassetta E, Tonali P Severe constipation in Parkinson's disease relieved by botulinum toxin. Movement Disorders, 12: 764-766, 1997
Bentivoglio AR, Bressman SB, Cassetta E,
Carretta D, Tonali P, Albanese A.
Analysis of blink rate patterns in
normal subjects.
Movement Disorders, 12: 1028-1034, 1997
Maria G, Cassetta
E, Gui D, Brisinda G, Bentivoglio AR, Albanese A. A comparison of
botulinum toxin and saline injections for treatment of chronic anal
fissure. New England Journal of Medicine, 338: 217-220, 1998
Gilman S, Low P,
Quinn N, Albanese A, Ben-Shlomo Y, Fowler C, Kaufmann H, Klockgether
T, Lang A, Lantos P, Litvan I, Mathias C, Oliver E, Robertson D,
Schatz I, Wenning G. Consensus statement on the diagnosis of
multiple system atrophy. Clinical Autonomic Research, 8: 359-362,
1998
Defazio G,
Berardelli A, Abbruzzese G, Lepore V, Coviello V, Acquistapace D,
Capus L, Carella F, De Berardinis MT, Galardi G, Girlanda P, Maurri
S, Albanese A, Bertolasi L, Liguori R, Rossi A, Santoro L, Tognoni
G, Livrea P. Possible risk factors for primary adult onset dystonia:
a case-control investigation by the Italian Movement Disorders Study
Group. Journal of Neurology, Neurosurgery & Psychiatry, 64: 25-32,
1998
Gilman S, Low P,
Quinn N, Albanese A, Ben-Shlomo Y, Fowler C, Kaufmann H, Klockgether
T, Lang A, Lantos P, Litvan I, Mathias C, Oliver E, Robertson D,
Schatz I, Wenning G. Consensus statement on the diagnosis of
multiple system atrophy. Journal of the Autonomic Nervous System,
74: 189-192, 1998
Maria G, Brisinda
G, Bentivoglio AR, Cassetta E, Gui D, Albanese A Botulinum toxin
injections in the internal anal sphincter for the treatment of
chronic anal fissure. Long-term results after two different dose
regimens. Annals of Surgery, 228: 664-669, 1998
Albanese A. The
current model of basal ganglia organization: a clinician’s view.
Movement Disorders, 13: 980-981, 1998
Maria G, Destito
A, Lacquaniti S, Bentivoglio AR, Brisinda G, Albanese A. Relief by
botulinum toxin of voiding dysfunction due to prostatitis. Lancet,
352: 625, 1998
Gilman S, Low PA,
Quinn N, Albanese A, Ben Shlomo Y, Fowler CJ, Kaufmann H,
Klockgether T, Lang AE, Lantos PL, Litvan I, Mathias CJ, Oliver E,
Robertson D, Schatz I, Wenning GK. Consensus statement on the
diagnosis of multiple system atrophy. Journal of the Neurological
Sciences, 163: 94-98, 1999
Moro E, Albanese
A. Apomorphine and levodopa challenge in patients with a focal
midbrain lesion. Movement Disorders, 14: 269-275, 1999
Rossi P, Albanese
A, Moro E, Genuardi M, Tonali P. Clinical genetic study of familial
Parkinson’s disease in Italy. Advances in Neurology, 80: 181-186,
1999
LeWitt PA,
Albanese A. New delivery systems for antiparkinsonian drugs.
Advances in Neurology, 80: 549-554, 1999
Albanese A,
Nordera GP, Caraceni T, Moro E. Long-term ventralis intermedius
thalamic stimulation for parkinsonian tremor. Italian Registry for
Neuromodulation in Movement Disorders. Advances in Neurology, 80:
631-634, 1999
Moro E, Scerrati
M, Romito LMA, Roselli R, Tonali P, Albanese A. Chronic subthalamic
nucleus stimulation reduces medication requirements in Parkinson’s
disease. Neurology, 53: 85-90, 1999
Defazio G,
Berardelli A, Abbruzzese G, Coviello V, Carella F, De Berardinis T,
Galardi G, Girlanda P, Maurri S, Mucchiur M, Albanese A, Basciani M,
Bertolasi L, Liguori R, Tambasco N, Santoro L, Assennato G, Livrea
P. Risk factors for spread of primary adult onset blepharospasm: a
multicentre investigation of the Italian movement disorders study
group. Journal of Neurology, Neurosurgery & Psychiatry, 67: 613-619,
1999
Ghika J,
Ghika-Schmid F, Frankhauser H, Assal G, Vingerhoets F, Albanese A,
Bogousslavsky J, Favre J. Bilateral contemporaneous posteroventral
pallidotomy for the treatment of Parkinson's disease:
neuropsychological and neurological side effects. Report of four
cases and review of the literature. Journal of Neurosurgery, 91:
313-321, 1999
Cassetta E, Del Grosso N, Bentivoglio AR, Valente EM, Frontali M, Albanese A. Italian family with cranial cervical dystonia: clinical and genetic study. Movement Disorders, 14: 820-825, 1999
Jarman PR, Del Grosso N, Valente EM, Leube
B, Cassetta E, Bentivoglio AR, Waddy HM, Uitti RJ, Maraganore DM,
Albanese A, Frontali M, Auburger G, Bressman SB, Wood NW, Nygaard
TG. Primary
torsion dystonia: the search for genes is not over. Journal of
Neurology Neurosurgery & Psychiatry, 67: 395-397, 1999
Brisinda G, Maria
G, Bentivoglio AR, Cassetta E, Gui D, Albanese A. A comparison of
injections of botulinum toxin and topical nitroglycerin ointment for
the treatment of chronic anal fissure. New England Journal of
Medicine, 341: 65-69, 1999
Bentivoglio AR,
Albanese A. Botulinum toxin in motor disorders. Current Opinion in
Neurology, 12: 447-456, 1999
Koller WC, Pahwa
R, Lyons KE, Albanese A. Surgical treatment of Parkinson’s disease.
Journal of the Neurological Sciences, 167: 1-10, 1999
Agid Y, Ahlskog
E, Albanese A, Calne D, Chase T, De Yebenes J, Factor S, Fahn S,
Gershanik O, Goetz C, Koller W, Kurth M, Lang A, Lees A, Lewitt P,
Marsden D, Melamed E, Michel PP, Mizuno Y, Obeso J, Oertel W, Olanow
W, Poewe W, Pollak P, Tolosa E. Levodopa in the treatment of
Parkinson's disease: a consensus meeting. Movement Disorders, 14 :
911-913, 1999
The
Epidemiological Study of Dystonia in Europe (ESDE) Collaborative
Group. Sex-related influences on the frequency and age of onset of
primary dystonia. Neurology, 53: 1871-1873, 1999
Guridi J, Rodriguez-Oroz MC, Lozano AM, Moro E, Albanese A, Nuttin B, Gybels J, Ramos E, Obeso JA. Targeting the basal ganglia for deep brain stimulation. Neurology, 55 (Suppl. 6): S21-S28, 2000
Rossi P, Colosimo C, Moro E, Tonali P, Albanese A. Acute challenge with apomorphine and levodopa in parkinsonism. European Neurology, 43: 95-101, 2000
Maria G, Brisinda G, Bentivoglio AR,
Cassetta E, Albanese.
Botulinum toxin
in the treatment of outlet obstruction constipation due to
puborectalis syndrome. Diseases of the Colon and Rectum, 43:
376-380, 2000
Albanese A,
Bentivoglio AR, Del Grosso N, Cassetta E, Frontali M, Valente EM,
Tonali P. Phenotype variability of dystonia in monozygotic twins.
Journal of Neurology, 247: 148-150, 2000
Maria G, Brisinda
G, Bentivoglio AR, Cassetta E, Gui D, Albanese A. Influence of
botulinum toxin site of injections on healing rate in patients with
chronic anal fissure. American Journal of Surgery, 179: 46-50, 2000
The
Epidemiological Study of Dystonia in Europe (ESDE) Collaborative
Group. A prevalence study of primary dystonia in eight European
countries. Journal of Neurology, 247: 787-792, 2000
Jahanshahi M, Ardouin CMA, Brown RG, Rothwell JC, Obeso J, Albanese A, Rodriguez-Oroz MC, Moro E, Benabid AL, Pollak P, Limousin-Dowsey P. The impact of deep brain stimulation on executive function in Parkinson’s disease. Brain, 123: 1142-1154, 2000
Gui D, De Gaetano A, Spada PL, Viggiano A, Cassetta E, Albanese A. Botulinum toxin injected in the gastric wall reduces body weight and food intake in rats. Alimentary Pharmacology and Therapeutics, 14: 829-834, 2000
Valente EM, Bentivoglio AR, Cassetta E, Dixon PH, Davis MB, Ferraris A, Ialongo T, Frontali M, Wood NW, Albanese A. DYT13, a novel primary torsion dystonia locus, maps to chromosome 1p36.13-36.32 in an Italian family with cranial-cervical or upper limb onset. Annals of Neurology, 49: 362-366, 2001
Valente EM, Bentivoglio AR, Dixon PH, Ferraris A, Ialongo T, Frontali M, Albanese A, Wood NW. Localization of a novel autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36. American Journal of Human Genetics, 68: 895-900, 2001
Albanese A, Bonuccelli U, Brefel C, Chaudhuri KR, Colosimo C, Eichhorn T, Melamed E, Pollak P, Van Laar T, Zappia M. Consensus statement on the role of acute dopaminergic challenge in Parkinson’s disease. Movement Disorders, 16: 197-201, 2001
Albanese A. The current status and use of botulinum toxins. European Journal of Neurology, 8 (Suppl. 4): 3-7, 2001
Priori A, Cinnante C, Genitrini S, Pesenti A, Tortora G, Bencini C, Barelli MV, Buonamici V, Carella F, Girotti F, Soliveri P, Magrini F, Morganti A, Albanese A, Broggi S, Scarlato G, Barbieri S. Non-motor effects of deep brain stimulation of the subthalamic nucleus in Parkinson's disease: preliminary physiological results. Neurological Sciences, 22: 85-86, 2001
Valente EM, Bentivoglio AR, Cassetta E, Dixon PH, Davis MB, Ferraris A, Ialongo T, Frontali M, Wood NW, Albanese A. Identification of a novel primary torsion dystonia locus (DYT13) on chromosome 1p36 in an Italian family with cranial-cervical or upper limb onset. Neurological Sciences, 22: 95-96, 2001
Maria G, Brisinda G, Bentivoglio AR, Albanese A, Sganga G, Castagneto M. Anterior rectocele due to obstructed defecation relieved by botulinum toxin. Surgery, 129: 524-529, 2001
The deep-brain stimulation for Parkinson's disease study group. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. New England Journal of Medicine, 345: 956-963, 2001
Bentivoglio AR, Cortelli P, Valente EM, Ialongo T, Ferraris A, Elia A, Montagna P, Albanese A. Phenotypic characterisation of autosomal recessive PARK6-linked parkinsonism in three unrelated Italian families. Movement Disorders, 16: 999-1006, 2001
Brisinda G, Maria G, Sganga G, Bentivoglio AR, Albanese A, Castagneto M. Effectiveness of higher doses of botulinum toxin to induce healing in patients with chronic anal fissure. Surgery, 131: 179-184, 2002
Valente EM, Brancati F, Ferraris A, Graham EA, Davis MB, Breteler MM, Gasser T, Bonifati V, Bentivoglio AR, De Michele G, Durr A, Cortelli P, Wassilowsky D, Harhangi BS, Rawal N, Caputo V, Filla A, Meco G, Oostra BA, Brice A, Albanese A, Dallapiccola B, Wood NW. PARK6-linked parkinsonism occurs in several European families. Annals of Neurology, 51: 14-18, 2002
Romito LM, Scerrati M, Contarino MF, Bentivoglio AR, Tonali P, Albanese A. Long-term follow up of subthalamic nucleus stimulation in Parkinson’s disease. Neurology, 58: 1546-1550, 2002
Bentivoglio AR, Loi M, Valente EM, Ialongo T, Tonali P, Albanese A. Phenotypic variability of DYT1-PTD: does the clinical spectrum include psychogenic dystonia? Movement Disorders, 17: 1058-1063, 2002
Romito LM, Raja M, Daniele A, Contarino MF, Bentivoglio AR, Barbier A, Scerrati M, Albanese A. Transient mania with hypersexuality following surgery for high frequency stimulation of the subthalamic nucleus in Parkinson’s disease. Movement Disorders, 17: 1371-1374, 2002
Soliveri P, Monza D, Piacentini S, Paridi D, Nespolo C, Gellera C, Mariotti C, Albanese A, Girotti F. Cognitive and psychiatric characterization of patients with Huntington's disease and their at-risk relatives. Neurological Sciences, 23 (Suppl. 2): S105-S106, 2002
Albanese A Dystonia in parkinsonian syndromes. Advances in Neurology, 91: 351-360, 2002
Khan NL, Valente EM, Bentivoglio AR, Wood NW, Albanese A, Brooks DJ, Piccini P. Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: An 18F-dopa PET study. Annals of Neurology, 52: 849-853, 2002
Restuccia D, Valeriani M, Barba C, Le Pera D, Bentivoglio A, Albanese A, Rubino M, Tonali P. Abnormal gating of somatosensory inputs in essential tremor. Clinical Neurophysiology, 114: 120-129, 2003
Daniele A, Albanese A, Romito LMA, Barbier A, Contarino MF, Gasparini F, Bentivoglio AR, Zinzi P. Cognitive and behavioural effects of chronic subthalamic nucleus stimulation in Parkinson’s disease. Journal of Neurology Neurosurgery & Psychiatry, 74: 175-182, 2003
Brisinda G, Civello IM, Albanese A, Maria G. Gastrointestinal smooth muscles and sphincters spasms: treatment with botulinum neurotoxin. Current Medicinal Chemistry, 10: 603-623, 2003
Carella F, Bressanelli M, Piacentini S, Soliveri P, Geminiani G, Monza D, Albanese A, Girotti F. A study of arm movements in Huntington's disease under visually controlled and blindfolded conditions. Neurological Sciences, 23: 287-293, 2003
Albanese A, Colosimo C. Dihydroergocriptine in Parkinson’s disease: clinical efficacy and comparison with other dopamine agonists. Acta Neurologica Scandinavica, 107: 349-355, 2003
Albanese A, Brisinda G, Bentivoglio AR, Maria G. Treatment of outlet obstruction constipation in Parkinson's disease with botulinum neurotoxin A. American Journal of Gastroenterology, 98: 1439-1440, 2003
Broggi G, Franzini A, Marras C, Romito L, Albanese A. Surgery of Parkinson's disease: inclusion criteria and follow-up. Neurological Sciences, 24 (Suppl. 1): S38-S40, 2003
Maria G, Brisinda G, Civello IM, Bentivoglio AR, Sganga G, Albanese A. Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia. Results of a randomised, placebo-controlled study. Urology, 62: 259-264, 2003
Soliveri P, Rossi G, Monza D, Tagliavini F, Piacentini S, Albanese A, Bugiani O, Girotti F. A case of dementia parkinsonism resembling progressive supranuclear palsy due to mutation in the tau protein gene. Archives of Neurology, 60: 1454-1456, 2003
Albanese A. The clinical expression of primary dystonia. Journal of Neurology, 250: 1145-1151, 2003
Brancati F; Valente EM; Castori M; Vanacore N; Sessa M; Galardi G; Berardelli A; Bentivoglio AR; Defazio G; Girlanda P; Abbruzzese G; Albanese A; Dallapiccola B. Role of the dopamine D5 receptor (DRD5) as a susceptibility gene for cervical dystonia. Journal of Neurology Neurosurgery and Psychiatry, 74: 665-666, 2003
Bentivoglio AR, Elia A, Filippini G, Valente EM, Fasano A, Albanese A. Clinical presentation and progression of sporadic and familial primary torsion dystonia in Italy. Advances in Neurology, 94: 171-178, 2004
Bentivoglio AR, Ialongo T, Contarino MF, Valente EM, Albanese A. Phenotypic characterisation of DYT13 primary torsion distonia. Movement Disorders, 19: 200-206, 2004
Brisinda G, Bentivoglio AR, Maria G, Albanese A. Treatment with botulinum neurotoxin of gastrointestinal smooth muscles and sphincters spasms. Movement Disorders, 19 (Suppl. 8): S146-S156, 2004
Valente EM, Abou-Sleiman PM, Caputo V, Muqit MMK, Harvey K, Gispert S, Ali Z, Del Turco D, Bentivoglio AR, Healy DG, Albanese A, Nussbaum R, González-Maldonado R, Deller T, Salvi S, Cortelli P, Gilks WP, Latchman DS, Harvey RJ, Dallapiccola B, Auburger G, Wood NW. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science, 304: 1158-1160, 2004
Rossi G, Gasparoli E, Pasquali C, Di Fede G, Testa D, Albanese A, Bracco F, Tagliavini F. Progressive supranuclear palsy and Parkinson's disease in a family with a new mutation in the tau gene. Annals of Neurology, 55: 448, 2004
Brisinda G, Albanese A, Cadeddu F, Bentivoglio AR, Mabisombi A, Marniga G, Maria G. Botulinum neurotoxin to treat chronic anal fissure: results of a randomized "Botox vs. Dysport" controlled trial. Alimentary Pharmacology and Therapeutics, 19: 695-701, 2004
Valente EM, Salvi S, Ialongo T, Marongiu R, Elia AE, Caputo V, Romito L, Albanese A, Dallapiccola B, Bentivoglio AR. PINK1 mutations are associated with sporadic early onset parkinsonism. Annals of Neurology, 56: 336-341, 2004
Emre M, Aarsland D, Albanese A, Byrne EJ, Deuschl G, De Deyn PP, Durif F, Kulisevsky J, van Laar T, Lees A, Poewe W, Robillard A, Rosa MM, Wolters E, Quarg P, Tekin S, Lane R. Rivastigmine for dementia associated with Parkinson's disease. New England Journal of Medicine, 351: 2509-2518, 2004
Olanow CW, Agid Y, Mizuno Y, Albanese A, Bonuccelli U, Damier P, De Yebenes J, Gershanik O, Guttman M, Grandas F, Hallett M, Hornykiewicz O, Jenner P, Katzenschlager R, Langston WJ, LeWitt P, Melamed E, Mena MA, Michel PP, Mytilineou C, Obeso JA, Poewe W, Quinn N, Raisman-Vozari R, Rajput AH, Rascol O, Sampaio C, Stocchi F. Levodopa in the treatment of Parkinson’s disease: current controversies. Movement Disorders, 19: 997-1005, 2004
Marelli C, Piacentini S, Garavaglia B, Girotti F, Albanese A. Clinical and neuropsychological correlates in two brothers with pantothenate kinase-associated neurodegeneration. Movement Disorders, 20: 208-212, 2005
Romito LMA, Contarino MF, Ghezzi D, Franzini A, Garavaglia B, Albanese A. High frequency stimulation of the subthalamic nucleus is efficacious in Parkin disease. Journal of Neurology, 252: 208-211, 2005
Pellecchia MT, Valente EM, Cif L, Salvi S, Albanese A, Scarano V, Bonuccelli U, Bentivoglio AR, D'Amico A, Marelli C, Di Giorgio A, Coubes P, Barone P, Dallapiccola B. The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration. Neurology, 64: 1810-1812, 2005
Albanese A, Valente EM, Romito L, Bellacchio E, Elia A, Dallapiccola B. The PINK1 phenotype can be indistinguishable from idiopathic Parkinson’s disease. Neurology, 64: 1958-1960, 2005
Ghezzi D, Marelli C, Achilli A, Goldwurm S, Pezzoli G, Barone P, Pellecchia MT, Stanzione P, Brusa L, Bentivoglio AR, Bonuccelli U, Petrozzi L, Abbruzzese G, Marchese R, Cortelli P, Grimaldi D, Martinelli P, Ferrarese C, Garavaglia B, Carelli V, Torroni A, Albanese A, Zeviani M. Mitochondrial DNA haplogroup K is associated with lower risk of idiopathic adult-onset Parkinson’s disease in Italians. European Journal of Human Genetics, 13: 748-752, 2005
Albanese A, Piacentini S, Romito LM, Leone M, Franzini A, Broggi G, Bussone G. Suicide after successful deep brain stimulation for movement disorders. Neurology, 65: 499-500, 2005
Rodriguez-Oroz MC, Obeso JA, Lang AE, Houeto JL, Pollak P, Rehncrona S, Kulisevsky J, Albanese A, Volkmann J, Hariz MI, Quinn NP, Speelman JD, Guridi J, Zamarbide I, Gironell A, Molet J, Pascual-Sedano B, Pidoux B, Bonnet AM, Agid Y, Xie J, Benabid AL, Lozano AM, Saint-Cyr J, Romito L, Contarino MF, Scerrati M, Fraix V, Van Blercom N. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain, 128: 2240-2249, 2005
Geser F, Seppi K, Stampfer-Kountchev M, Kollensperger M, Diem A, Ndayisaba J,P, Ostergaard K, Dupont E, Cardozo A, Tolosa E, Abele M, Dodel R, Klockgether T, Ghorayeb I, Yekhlef F, Tison F, Daniels C, Kopper F, Deuschl G, Coelho M, Ferreira J, Rosa M,M, Sampaio C, Bozi M, Schrag A, Hooker J, Kim H, Scaravilli T, Mathias C,J, Fowler C, Wood N, Quinn N, Widner H, Nilsson C,F, Lindvall O, Schimke N, Eggert K,M, Oertel W, Del Sorbo F, Carella F, Albanese A, Pellecchia M,T, Barone P, Djaldetti R, Meco G, Colosimo C, Gonzalez-Mandly A, Berciano J, Gurevich T, Giladi N, Galitzky M, Ory F, Rascol O, Kamm C, Buerk K, Maass S, Gasser T, Poewe W, Wenning GK. The European Multiple System Atrophy-Study Group (EMSA-SG), Journal of Neural Transmission, 112: 1677-1686, 2005
Albanese A, Barnes MP, Bhatia KP, Fernandez-Alvarez E, Filippini G, Gasser T, Krauss JK, Newton A, Rektor I, Savoiardo M, Valls-Solè J. A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS/MDS-ES Task Force. European Journal of Neurology, 13; 493-444, 2006
Schrag A, Geser F, Stampfer-Kountchev M, Seppi K, Sawires M, Köllensperger M, Scherfler C, Quinn N, Pellecchia MT, Barone P, Del Sorbo F, Albanese A, Ostergaard K, Dupont E, Cardozo A, Tolosa E, Nilsson CF, Widner H, Lindvall O, Giladi N, Gurevich T, Daniels C, Deuschl G, Coelho M, Sampaio C, Abele M, Klockgether T, Schimke N, Eggert KM, Oertel W, Djaldetti R, Colosimo C, Meco G, Poewe W, Wenning GK. Health-related quality of life in multiple system atrophy. Movement Disorders, 21: 809-815, 2006
Brisinda G, Maria G, Bentivoglio AR, Cadeddu F, Marniga G, Brandara F, Albanese A. Management of bladder, prostatic and pelvic floor disorders. Neurotoxicity Research, 9: 161-172, 2006
Saint-Cyr JA, Albanese A. STN DBS in PD: selection criteria for surgery should include cognitive and psychiatric factors. Neurology, 66: 1799-1800, 2006
Bentivoglio AR, Daniele A, Albanese A, Tonali PA, Fasano A. Analysis of blink rate in patients with blepharospasm. Movement Disorders, 21: 1225-1229, 2006
Elia AE, Filippini G, Bentivoglio AR, Fasano A, Ialongo T, Albanese A. Onset and progression of primary torsion dystonia in sporadic and familial cases. European Journal of Neurology, 13: 1083-1088, 2006
Marongiu R, Ghezzi D, Ialongo T, Soleti F, Elia A, Cavone S, Albanese A, Altavista MC, Barone P, Brusa L, Cortelli P, Petrozzi L, Scaglione C, Stanzione P, Tinazzi M, Zeviani M, Dallapiccola B, Bentivoglio AR, Valente EM, Garavaglia B. Frequency and phenotypes of LRRK2 G2019S mutation in Italian patients with Parkinson's disease. Movement Disorders, 21: 1232-1235, 2006
Fasano A, Nardocci N, Elia AE, Zorzi G, Bentivoglio AR, Albanese A. Non-DYT1 early onset primary torsion dystonia: comparison with DYT1 phenotype and review of the literature. Movement Disorders, 21: 1411-1418, 2006
Naumann M, Albanese A, Heinen F, Molenaers G, Relja M. Safety and efficacy of botulinum toxin type A following long-term use. European Journal of Neurology, 13 (Suppl 4): 35-40, 2006
Köllensperger M, Stampfer-Kountchev M, Seppi K, Geser F, Frick C, Del Sorbo F, Albanese A, Gurevich T, Giladi N, Djaldetti R, Schrag A, Fowler C, Low PA, Mathias CJ, Poewe W, Wenning GK. Progression of dysautonomia in multiple system atrophy: a prospective study of self-perceived impairment. European Journal of Neurology, 14: 66-72, 2007
Contarino MF, Daniele A, Sibilia AH, Romito LM, Bentivoglio AR, Gainotti G, Albanese A. Cognitive outcome five years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson's disease. Journal of Neurology Neurosurgey and Psychiatry, 78: 248-252, 2007
Romito LM, Franzini A, Perani D, Carella F, Marras C, Capus L, Garibotto V, Broggi G, Albanese A. Fixed dystonia unresponsive to pallidal stimulation improved by motor cortex stimulation. Neurology, 68: 875-876, 2007
Del Sorbo F, Elia AE, De Joanna G, Romito L.M, Garavaglia B, Albanese A. Normal cardiovascular reflex testing in patients with parkin disease. Movement Disorders, 22: 528-532, 2007
Albanese A. Can falls be prevented in Parkinson’s disease? Journal of Neurology Neurosurgey and Psychiatry, 78: 661, 2007
Cordella R, Carella F, Leone M, Franzini A, Broggi G, Bussone G, Albanese A. Spontaneous neuronal activity of the posterior hypothalamus in trigeminal autonomic cephalalgias. Neurological Sciences, 28: 93-95, 2007
Albanese A. Dystonia: clinical approach. Parkinsonism and Related Disorders, 13: S356-S361, 2007
Piacentini S, Romito L, Franzini A, Granato A, Broggi G, Albanese A. Mood disorder following DBS of the left amygdaloid region in a dystonia patient with a dislodged electrode. Movement Disorders, 23: 147-150, 2008
Fiorio M, Gambarin M, Defazio G, Valente EM, Stanzani C, Moretto G, Loi M, Soliveri P, Nardocci N, Albanese A, Fiaschi A, Tinazzi M. Impaired body movement representation in DYT1 mutation carriers. Clinical Neurophysiology, 119: 1864-1869, 2008
Defazio G, Berardelli A, Fabbrini G, Martino D, Fincati E, Fiaschi A, Moretto G, Abbruzzese G, Marchese R, Bonuccelli U, Del Dotto P, Barone P, De Vivo E, Albanese A, Antonini A, Canesi M, Lopiano L, Zibetti M, Nappi G, Martignoni E, Lamberti P, Tinazzi M. Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study. Archives of Neurology, 65: 1191-1194, 2008
Kollensperger M, Geser F, Seppi K, Stampfer-Kountchev M, Sawires M, Scherfler C, Boesch S, Mueller J, Koukouni V, Quinn N, Pellecchia MT, Barone P, Schimke N, Dodel R, Oertel W, Dupont E, Ostergaard K, Daniels C, Deuschl G, Gurevich T, Giladi N, Coelho M, Sampaio C, Nilsson C, Widner H, Sorbo FD, Albanese A, Cardozo A, Tolosa E, Abele M, Klockgether T, Kamm C, Gasser T, Djaldetti R, Colosimo C, Meco G, Schrag A, Poewe W, Wenning GK. Red flags for multiple system atrophy. Movement Disorders, 23: 1093-1099, 2008
Lalli S, Albanese A. Rivastigmine in Parkinson’s disease. Expert Review in Neurotherapeutics, 8: 1181-1188, 2008
Pagni CA , Albanese A, Bentivoglio A, Broggi G, Canavero S, Cioni B, Rose MD, Simone CD, Franzini A, Lavano A, Landi A, Meglio M, Modugno M, Romanelli L, Romito LM, Sturiale C, Valzania F, Zeme S, Zenga F. Results by motor cortex stimulation in treatment of focal dystonia, Parkinson's disease and post-ictal spasticity. The experience of the Italian Study Group of the Italian Neurosurgical Society. Acta Neurochirurgica Supplement, 101: 13-21, 2008.
Del Sorbo F., Albanese A. Levodopa-induced dyskinesias and their management. Journal of Neurology, 255 (Supplement 4): 32-41, 2008.
Marongiu R, Ferraris A, Ialongo T, Cavone S, Soleti F, Michiorri S, Elia AE, Ghezzi D, Albanese A, Altavista MC, Antonini A, Barone P, Brusa L, Cortelli P, Goldwurm S, Martinelli P, Pellecchia MT, Pezzoli G, Scaglione C, Stanzione P, Tinazzi M, Garavaglia B, Dallapiccola B, Bentivoglio AR, Valente EM, and the Italian PD Study Group. PINK1 heterozygous rare variants: prevalence, significance and phenotypic spectrum. Human Mutation, 29: 565, 2008.
Fiorio M, Valente EM, Gambarin M, Bentivoglio AR, Ialongo T, Albanese A, Barone P, Pellecchia MT, Brancati F, Moretto G, Fiaschi A, Tinazzi M. Subclinical sensory abnormalities in unaffected PINK1 heterozygotes. Journal of Neurology, 255: 1372-1377, 2008.
Bentivoglio AR, Fasano A, Ialongo T, Soleti F, Lo Fermo S, Albanese A. Outcome predictors, efficacy and safety of Botox and Dysport in the long term treatment of hemifacial spasm. European Journal of Neurology, 16: 392-398, 2009.
Bentivoglio AR, Fasano A, Ialongo T, Soleti F, Lo Fermo S, Albanese A. Fifteen-Year Experience in Treating Blepharospasm with Botox or Dysport: same toxin, two drugs. Neurotoxicity Research, 15: 224-231, 2009.
Romito LM, Contarino MF, Vanacore N, Bentivoglio AR, Scerrati M, Albanese A. Replacement of dopaminergic medication with subthalamic nucleus stimulation in Parkinson's disease: long-term observation. Movement Disorders, 24: 557-563, 2009.
Elia AE, Filippini G, Calandrella D, Albanese A. Botulinum neurotoxins for post-stroke spasticity in adults: a systematic review. Movement Disorders: 24, 801-812, 2009.
Albanese A, Bigalke H, Foster K, Hallett M, Jankovic J, Montecucco C, Schiavo G. Foreword. Toxicon, 54: 549, 2009.
Esquenazi A, Mayer NH, Elia AE, Albanese A. Botulinum toxin for the management of adult patients with upper motor neuron syndrome. Toxicon, 54: 634-638, 2009.
Jankovic J, Albanese A, Hallett M. Unique properties of botulinum toxins. Toxicon, 54: 675, 2009.
Albanese A. Discussion of unique properties of botulinum toxins. Toxicon, 54: 702-708, 2009.
Albanese A, Lalli S. Is this dystonia? Movement Disorders, 24: 1725-1731, 2009.
Gattellaro G, Minati L, Grisoli M, Mariani C, Carella F, Osio M, Ciceri E, Albanese A., Bruzzone MG. White matter involvement in idiopathic Parkinson disease: a diffusion tensor imaging study. American Journal of Neuroradiology, 30: 1222-1226, 2009.
Volkmann J, Albanese A, Kulisevsky J, Tornqvist AL, Houeto JL, Pidoux B, Bonnet AM, Mendes A, Benabid AL, Fraix V, Van Blercom N, Xie J, Obeso J, Rodriguez-Oroz MC, Guridi J, Schnitzler A, Timmermann L, Gironell AA, Molet J, Pascual-Sedano B, Rehncrona S, Moro E, Lang AC, Lozano AM, Bentivoglio AR, Scerrati M, Contarino MF, Romito L, Janssens M, Agid Y. Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease. Movement Disorders, 24: 1154-1161, 2009.
Ferraris A, Ialongo T, Passali GC, Pellecchia MT, Brusa L, Baruffa M, Guidubaldi A, Plaudetti G, Albanese A, Barone P, Dallapiccola B, Valente EM, Bentivoglio AR. Olfactory dysfunction in parkinsonism caused by PINK1 mutations. Movement Disorders: 24: 2350-2357, 2009.
Bonetti M, Barzaghi C, Brancati F, Ferraris A, Bellacchio E, Giovanetti A, Ialongo T, Zorzi G, Piano C, Petracca M, Albanese A, Nardocci N, Dallapiccola B, Bentivoglio A.R, Garavaglia B, Valente EM. Mutation screening of the DYT6/THAP1 gene in Italy. Movement Disorders, 24: 2424-2427, 2009.
Moro E, Lozano A.M, Pollak P, Agid Y, Rehncrona S, Volkmann J, Kulisevsky J, Obeso JA, Albanese A, Hariz M.I, Quinn N.P, Speelman JD, Benabid AL, Fraix V, Mendes A, Welter ML, Houeto JL, Cornu P, Dormont D, Tornqvist AL, Ekberg R, Schnitzler A, Timmermann L, Wojtecki L, Gironell A, Rodriguez-Oroz M.C, Guridi J, Bentivoglio AR, Contarino MF, Romito L, Scerrati M, Janssens M, Lang AE. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Movement Disorders, 25: 578-586, 2010.
Romito LM, Contarino FM, Albanese A. Transient gender-related effects in Parkinson's disease patients with subthalamic stimulation. Journal of Neurology, 257: 603-608, 2010.
Lalli S, Albanese A. The diagnostic challenge of primary dystonia: evidence from misdiagnosis. Movement Disorders, 25: 1619-1626, 2010.
Elia AE, Lalli S, Albanese A. Differential diagnosis of dystonia. European Journal of Neurology, 17 (Suppl. 1): 1-8, 2010.
Fasano A, Romito LM, Daniele A, Piano C, Zinno M, Bentivoglio AR, Albanese A. Motor and cognitive outcome in patients with Parkinson’s disease 8 years after subthalamic implants. Brain, 133: 2664-2676, 2010.
Albanese A, Asmus F, Bhatia K, Elia A, Elibol B, Filippini G, Gasser T, Krauss J, Nardocci N, Newton A, Valls-Solé J. EFNS guidelines on diagnosis and treatment of primary dystonias. European Journal of Neurology, 18: 5-18, 2011.
Albanese A. Terminology for preparations of botulinum neurotoxins: what a difference a name makes. JAMA Journal of the American Medical Association, 305: 89-90, 2011.
Albanese A. I gangli motori e i disturbi del movimento. Piccin, Padova, 495 pagine, 1991
Albanese A, Bentivoglio AR, Tonali P. I disturbi del movimento. Poli, Milano, 1993. Volume di 71 pagine e videocassetta di 30 minuti
Bentivoglio AR, Cassetta E, Albanese A, Tonali P. La tossina botulinica nel trattamento del blefarospasmo e dell’emispasmo facciale. Studio Armati & C, 1996. Videocassetta di 35 minuti.
Albanese A, Lee J, Moore AP, Naumann M. The Movement Disorder Society guide to botulinum toxin injections, a cura di Moore AP. Movement Disorder Society, 2002. CD interattivo
Butcher LL, Woolf
NJ, Albanese A, Butcher SH. Cholinergic-monoaminergic interactions
in selected regions of the brain: histochemical and pharmacological
analyses. Advances in Behavioral Biology, 25: 723-738, 1981
Amaducci L,
Bracco F, Sorbi S, Albanese A, Gainotti G. Right and left differ-ences
of cholinergic system in the human temporal lobes. Excerpta Medica
International Congress Series, 568: 289-297, 1981
Gozzo S, Iacopino
C, Altavista MC, Albanese A. Early senescence of forebrain
cholinergic neurons: a genetic animal model. Symposia in
Neuroscience, 3: 299-303, 1986
Oliverio A,
Albanese A, Altavista MC, Castellano C, Gozzo S, Macchi G. A genetic
approach to cholinergic ontogeny in the mouse. Current Problems in
Senile Dementias, 1: 555-560, 1986
Albanese A, Gozzo S, Altavista MC, Iacopino C, Rossi P. Morphometric study of cholinergic neurons in inbred strains of mice: genetically determined early loss of cholinergic neurons as a model of central nervous system cholinergic failure. In: Cellular and Molecular Basis for Cholinergic Function, a cura di Dowdall MJ, Hawthorne JN. VCH, Weinheim (Germania), pp. 684-688, 1987
Albanese A, Gozzo S, Altavista MC.
Loss of forebrain
cholinergic neurones induced by ageing and by genetic factors.
Current Problems in Senile Dementias, 2: 49-54, 1988
Albanese A.
Extrapyramidal system and extrapyramidal disorders. In: Neuroscience
across the centuries, a cura di Rose FC. Smith-Gordon and Company,
Londra, pp. 97-109, 1989
Albanese A,
Altavista MC, Colosimo C, Bentivoglio AR, Rossi P, Macchi G. Chronic
administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to
marmosets. Advances in Behavioral Biology, 39: 523-531, 1991
Ghika J, Albanese
A. Dyskinesias. In: Textbook of Neurology, a cura di Fisher M,
Bogousslavsky J, Butterworth-Heinemann, Newton (USA), pp. 247-254,
1998
Colosimo C,
Albanese A. La apomorfina: una herramienta diagnóstica y terapéutica.
In: Tratamiento de la Enfermedad de Parkinson, a cura di Merello M,
Lees AJ.
Talleres graficos de “La ley”, Buenos Aires (Argentina), pp. 99-116,
1999
Valente EM, Albanese A.
Autres troubles du mouvement héréditaires. In: Traité de Neurologie,
a cura di Bogousslavsky J, Mas J-L, Léger JM. Doin éditeurs,
Vélizy-Villacoublay (Francia), 2000
Albanese A, Brisinda G,
Mathias CJ The autonomic nervous system and gastrointestinal
disorders. In: The autonomic nervous system. Part II. Dysfunctions,
a cura di Vinken PJ, Bruyn GW. Handbook of Clinical Neurology, 75:
613-663, 2001
Bentivoglio AR, Cassetta E, Albanese A. Distonia. In: La malattia di Parkinson e i disturbi del movimento, a cura di Colosimo C, CIC edizioni internazionali, Roma, pp. 293-323, 2001
Brisinda G., Maria G., Bentivoglio A.R.,
Albanese A The role of botulinum toxin in gastrointestinal disorders.
In: Scientific
and therapeutic aspects of botulinum toxin, a cura di Brin MF,
Jankovic J, Hallett M. Lippincott, Williams & Wilkins, Philadelphia
(USA), pp. 269-285, 2002
Albanese A, Solida A. Disturbi del movimento. In: Malattie del Sistema Nervoso del Prof. Giorgio Macchi, a cura di Minciacchi D, Granato A. Volume 10 della serie Trattato di Medicina Interna. Piccin, Padova, pp 571-611, 2004.
Contarino MF,
Albanese A. Medical and surgical treatment of dystonia. In Dystonia,
Volume 3 della serie World Federation of Neurology Seminars in
Clinical Neurology, a cura di Munsat TL. Demos, New York (USA), pp.
31-42, 2005
Contarino MF, Albanese A. Hypersalivation.
In: Clinical uses
of botulinum toxins, a cura di Ward AB, Barnes MP, Cambridge
University press, Cambridge (UK), pp. 201-228, 2007
Albanese A, Bentivoglio AR. Botulinum toxin in movement disorders. In: Parkinson Disease and Movement Disorders, quinta edizione, a cura di Jankovic J, Tolosa E, pp. 605-619, 2007
Elia AE, Bentivoglio AR, Valente EM,
Albanese A. Other Primary Generalised Dystonias.
In: Clinical
Diagnosis and Management of Distonia, a cura di Warner T, Bressman
S, Informa Healthcare, London, pp. 65-72, 2007